Aptevo Therapeutics Inc. — Form S-1
Filed November 20, 2026 · analyzed by the Registration Agent
S-1
▼ Likely negative
significance 72/100
What the filing says
Aptevo issued 13,888,890 Inducement Warrants on November 11, 2026 to three warrant holders (Armistice Capital, Hudson Bay, Sabby Volatility) at $1.08/share exercise price in exchange for immediate cash exercise of 2,777,778 existing warrants at reduced $1.08 price. The company received ~$3.0M gross proceeds from warrant exercise; if Inducement Warrants are exercised in full, company would receive ~$15.0M additional. Resale shares represent 79% of post-offering outstanding shares (13.9M of 17.5M total). Stock price on November 19, 2026: $0.41/share. This is a shelf registration for resale of warrant-exercise shares.
Why this rating
Massive dilution (79% share increase post-offering) relative to tiny $9.8M market cap; warrant exercise terms highly unfavorable to shareholders. Material capital raise offsets some concern.
Extracted items
- 2.02 results / earnings
- 7.01 Reg FD disclosure
Price action (we called it negative)
before filing · preread $0.40 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.